MAPT and Alzheimer disease: Convincing evidence strongly supports the amyloid cascade hypothesis (Selkoe & Hardy, 2016), which posits that Aβ oligomers in cerebral Aβ deposits are the main toxic molecules that trigger the subsequent downstream pathologies of AD, including glia pathology, Tau pathology, neurodegeneration, and synapse loss.